FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386255539> ?p ?o ?g. }

• W4386255539 endingPage "4303" @default.
• W4386255539 startingPage "4303" @default.
• W4386255539 abstract "We previously showed that upregulation of adipocyte enhancer-binding protein 1 (AEBP1) in vascular endothelial cells promotes tumor angiogenesis. In the present study, we aimed to clarify the role of stromal AEBP1/ACLP expression in oral squamous cell carcinoma (OSCC). Immunohistochemical analysis showed that ACLP is abundantly expressed in cancer-associated fibroblasts (CAFs) in primary OSCC tissues and that upregulated expression of ACLP is associated with disease progression. Analysis using CAFs obtained from surgically resected OSCCs showed that the expression of AEBP1/ACLP in CAFs is upregulated by co-culture with OSCC cells or treatment with TGF-β1, suggesting cancer-cell-derived TGF-β1 induces AEBP1/ACLP in CAFs. Collagen gel contraction assays showed that ACLP contributes to the activation of CAFs. In addition, CAF-derived ACLP promotes migration, invasion, and in vivo tumor formation by OSCC cells. Notably, tumor stromal ACLP expression correlated positively with collagen expression and correlated inversely with CD8+ T cell infiltration into primary OSCC tumors. Boyden chamber assays suggested that ACLP in CAFs may attenuate CD8+ T cell migration. Our results suggest that stromal ACLP contributes to the development of OSCCs, and that ACLP is a potential therapeutic target." @default.
• W4386255539 created "2023-08-30" @default.
• W4386255539 creator A5007356141 @default.
• W4386255539 creator A5011740610 @default.
• W4386255539 creator A5022198817 @default.
• W4386255539 creator A5023765303 @default.
• W4386255539 creator A5033141201 @default.
• W4386255539 creator A5036423798 @default.
• W4386255539 creator A5044409221 @default.
• W4386255539 creator A5044510659 @default.
• W4386255539 creator A5044870662 @default.
• W4386255539 creator A5046027322 @default.
• W4386255539 creator A5047756100 @default.
• W4386255539 creator A5049246136 @default.
• W4386255539 creator A5051622798 @default.
• W4386255539 creator A5054192961 @default.
• W4386255539 creator A5056654750 @default.
• W4386255539 creator A5057319578 @default.
• W4386255539 creator A5061939029 @default.
• W4386255539 creator A5063600818 @default.
• W4386255539 creator A5064856279 @default.
• W4386255539 creator A5071632526 @default.
• W4386255539 creator A5072637751 @default.
• W4386255539 creator A5073329813 @default.
• W4386255539 creator A5080167967 @default.
• W4386255539 creator A5082515974 @default.
• W4386255539 date "2023-08-28" @default.
• W4386255539 modified "2023-10-16" @default.
• W4386255539 title "ACLP Activates Cancer-Associated Fibroblasts and Inhibits CD8+ T-Cell Infiltration in Oral Squamous Cell Carcinoma" @default.
• W4386255539 cites W1519375111 @default.
• W4386255539 cites W1966736466 @default.
• W4386255539 cites W1971539003 @default.
• W4386255539 cites W2010031549 @default.
• W4386255539 cites W2012738107 @default.
• W4386255539 cites W2016548770 @default.
• W4386255539 cites W2019051236 @default.
• W4386255539 cites W2038746094 @default.
• W4386255539 cites W2047267313 @default.
• W4386255539 cites W2049015975 @default.
• W4386255539 cites W2053424592 @default.
• W4386255539 cites W2056687507 @default.
• W4386255539 cites W2062397335 @default.
• W4386255539 cites W2063721051 @default.
• W4386255539 cites W2068535366 @default.
• W4386255539 cites W2101448500 @default.
• W4386255539 cites W2101586744 @default.
• W4386255539 cites W2103470533 @default.
• W4386255539 cites W2111151703 @default.
• W4386255539 cites W2137044945 @default.
• W4386255539 cites W2154294588 @default.
• W4386255539 cites W2155384808 @default.
• W4386255539 cites W2201600912 @default.
• W4386255539 cites W2464937318 @default.
• W4386255539 cites W2512899508 @default.
• W4386255539 cites W2589485488 @default.
• W4386255539 cites W2750862728 @default.
• W4386255539 cites W2786031287 @default.
• W4386255539 cites W2792118669 @default.
• W4386255539 cites W2795052789 @default.
• W4386255539 cites W2863222417 @default.
• W4386255539 cites W2885532026 @default.
• W4386255539 cites W2898253860 @default.
• W4386255539 cites W2904712055 @default.
• W4386255539 cites W2911360266 @default.
• W4386255539 cites W2914487332 @default.
• W4386255539 cites W2949660068 @default.
• W4386255539 cites W2986633517 @default.
• W4386255539 cites W3003058300 @default.
• W4386255539 cites W3008753767 @default.
• W4386255539 cites W3026844837 @default.
• W4386255539 cites W3028654748 @default.
• W4386255539 cites W3128646645 @default.
• W4386255539 cites W3128802291 @default.
• W4386255539 cites W3183885500 @default.
• W4386255539 cites W4212852715 @default.
• W4386255539 cites W4283122432 @default.
• W4386255539 cites W4308604965 @default.
• W4386255539 doi "https://doi.org/10.3390/cancers15174303" @default.
• W4386255539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37686580" @default.
• W4386255539 hasPublicationYear "2023" @default.
• W4386255539 type Work @default.
• W4386255539 citedByCount "0" @default.
• W4386255539 crossrefType "journal-article" @default.
• W4386255539 hasAuthorship W4386255539A5007356141 @default.
• W4386255539 hasAuthorship W4386255539A5011740610 @default.
• W4386255539 hasAuthorship W4386255539A5022198817 @default.
• W4386255539 hasAuthorship W4386255539A5023765303 @default.
• W4386255539 hasAuthorship W4386255539A5033141201 @default.
• W4386255539 hasAuthorship W4386255539A5036423798 @default.
• W4386255539 hasAuthorship W4386255539A5044409221 @default.
• W4386255539 hasAuthorship W4386255539A5044510659 @default.
• W4386255539 hasAuthorship W4386255539A5044870662 @default.
• W4386255539 hasAuthorship W4386255539A5046027322 @default.
• W4386255539 hasAuthorship W4386255539A5047756100 @default.
• W4386255539 hasAuthorship W4386255539A5049246136 @default.
• W4386255539 hasAuthorship W4386255539A5051622798 @default.
• W4386255539 hasAuthorship W4386255539A5054192961 @default.
• W4386255539 hasAuthorship W4386255539A5056654750 @default.

• next